Seoul Consumer Group Urges Fast Passage of Tobacco Law to Regulate Synthetic Nicotine

Nov.21.2024
Seoul Consumer Group Urges Fast Passage of Tobacco Law to Regulate Synthetic Nicotine
The Seoul Consumer Civic Network urges swift passage of a Tobacco Business Act amendment to regulate synthetic nicotine e-cigarettes, emphasizing youth health protection and stricter enforcement.

The Seoul Consumer Civic Network in South Korea issued a statement urging the swift passage of an amendment to the Tobacco Business Act, according to a report by N.News on November 21. 

 

This amendment focuses on regulating synthetic nicotine-based e-cigarettes, which pose a significant threat to youth health. The organization called for immediate action from both the National Assembly and the government.

 

The statement highlighted a critical gap in the current Tobacco Business Act, which lacks legal provisions to regulate synthetic nicotine. As a result, e-cigarette products exploiting legal loopholes have become a serious health risk for teenagers. The network warned that the widespread use of unverified synthetic nicotine is jeopardizing youth health.

 

Additionally, the network pointed out that e-cigarettes with sweet flavors and designs that resemble cosmetics or school supplies are targeting young people. The easy availability of these products through vending machines and online shopping platforms has created significant risks for youth protection.

 

The Seoul Consumer Civic Network called on the National Assembly to pass the amendment by the end of the year, urged the government to implement regulations on synthetic nicotine products, and emphasized the need for stronger enforcement to safeguard youth.

 

Kim Tae-min, the head of the Seoul Consumer Civic Network, said, "We can no longer ignore synthetic nicotine e-cigarettes that endanger youth health and safety. The law must be passed by the end of this year, and we will continue to monitor and oversee the process until it is enacted."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Commissioner Urges DEA to Classify 7-OH Ingredient Used in E-Cigarettes as a Schedule I Controlled Substance
FDA Commissioner Urges DEA to Classify 7-OH Ingredient Used in E-Cigarettes as a Schedule I Controlled Substance
FDA Commissioner Robert Califf urged the DEA to classify 7-OH, an opioid-like compound found in vapes, drinks, and gummies, as a Schedule I substance. The FDA plans national warnings for doctors and tighter control of high concentrations.
Jul.30 by 2FIRSTS.ai
2Firsts Holds First Global NGP Compliance Certification Training (U.S. Edition), Building the World’s First Professional NGP Compliance Talent Program
2Firsts Holds First Global NGP Compliance Certification Training (U.S. Edition), Building the World’s First Professional NGP Compliance Talent Program
2Firsts held its first Global NGP Compliance Certification Training in Shenzhen, building international compliance talent and strengthening the industry’s global ecosystem.
Jul.14
U.S. Fourth Circuit Court Rules North Carolina Can Ban Sale of FDA-Unapproved E-Cigarette Products
U.S. Fourth Circuit Court Rules North Carolina Can Ban Sale of FDA-Unapproved E-Cigarette Products
The U.S. Fourth Circuit Court upheld North Carolina's right to ban the sale of FDA-unapproved e-cigarettes, rejecting an injunction request. Plaintiffs argued the state can't enforce FDA rules, but the state said halting the law would cause confusion. The case remains under review.
Jul.30 by 2FIRSTS.ai
Dutch Medical Institutions Urge Snapchat to Crack Down on E-cigarette Sales Content
Dutch Medical Institutions Urge Snapchat to Crack Down on E-cigarette Sales Content
Several Dutch medical and public health organizations have jointly sent a letter to Snapchat, urging the platform to strengthen its efforts in curbing e-cigarette promotion to protect youth from nicotine addiction. If no improvement is seen within 14 days, a formal complaint will be filed.
Jun.12 by 2FIRSTS.ai
Australia's New Vaping Law Leads to the Collapse of the Legal Market and a Surge in Black - market Transactions
Australia's New Vaping Law Leads to the Collapse of the Legal Market and a Surge in Black - market Transactions
Australia’s new vaping law has led to the collapse of the legal market and a surge in black - market transactions. The new regulations, which limit sales to pharmacies, have seen low participation and transaction volumes in the legal market, while black - market dealings have soared. Critics say the policy has fueled organized crime, and experts are calling for legalization and regulation to address the crisis.
Jun.23 by 2FIRSTS.ai
2Firsts Exclusive with ARAC: What Juul’s FDA Approval Reveals About U.S. Tobacco Regulation
2Firsts Exclusive with ARAC: What Juul’s FDA Approval Reveals About U.S. Tobacco Regulation
2Firsts spoke with the leadership team at ARAC to analyze the regulatory context and industry implications of the FDA’s approval of five Juul products. ARAC noted that the decision highlights FDA’s increasing emphasis on real-world switching behavior as a key criterion for authorization. While more MGOs may follow, companies must meet rigorous standards in toxicology, manufacturing, and population-level risk assessments.
Jul.21